Trade [[data.name]]

Sanofi is one of the leading pharmaceutical and healthcare companies in France and western Europe. Sanofi’s primary goal is to conduct ground-breaking research and development, alongside the manufacture of prescription-based and over-the-counter pharmaceuticals. The company now specialises in seven core areas, seeking to provide therapeutic support across the following areas – diabetes, oncology, vaccines, thrombosis, cardiovascular, central nervous system and internal medicine.

In terms of its vaccine production, it is now considered one of the world’s biggest producers via its subsidiary Sanofi Pasteur. However, it did lag behind several other pharmaceutical giants in the rapid development of Covid-19 vaccines, namely AstraZeneca. Other firms such as Moderna and Novavax were also able to bring their products to the market faster, forcing Sanofi to admit defeat. However, it still has plenty of ambitious targets for the future.

Founded: 1973, Paris, France
Founders: Jean-René Sautier and Jean-François Dehecq
Headquarters: 54 Rue La Boetie, Paris, France 75008

Sanofi shares are publicly listed on the Euronext Paris under the ticker symbol (SAN). Sanofi is now a key component in the FRA40 index, which comprises 40 of the most valuable listed companies in France. In the last five years, the Sanofi share price has risen over 22% between July 2017 and July 2022.

It reached an all-time high of $106.66 per share in April 2022, which was largely due to its ground-breaking collaboration with Regeneron for Dupixent, a treatment that’s on the verge of obtaining regulatory approval in the US to treat the rare skin condition known as prurigo nodularis.

Sanofi is one of the most prominent equities listed on the Euronext Paris exchange. As a world-leading pharmaceutical and healthcare company, it’s understandably one of the most valuable companies in the FRA40 – France’s leading index of its 40 most significant businesses. With that comes a significant price tag for those wishing to invest in Sanofi shares.

However, with contracts for difference (CFD) trading, it’s possible to make money on the Sanofi share price without even physically owning their shares. CFD trading offers two benefits over investing in the underlying asset. Firstly, you can open a leveraged position, depositing a small percentage of the full value of your market exposure upfront. Just be mindful that leveraged positions can maximise losses as well as profits. Secondly, you can short-sell the asset to profit if you believe the price of Sanofi shares will fall.